Chen, Hsiang-Han
Eteleeb, Abdallah
Wang, Ciyang
Fernandez, Maria Victoria
Budde, John P.
Bergmann, Kristy
Norton, Joanne
Wang, Fengxian
Ebl, Curtis
Morris, John C.
Perrin, Richard J.
Bateman, Randall J.
McDade, Eric
Xiong, Chengjie
Goate, Alison
Farlow, Martin
Chhatwal, Jasmeer
Schofield, Peter R.
Chui, Helena
Harari, Oscar
Cruchaga, Carlos
Ibanez, Laura http://orcid.org/0000-0003-2381-7059
,
Funding for this research was provided by:
Alzheimer's Drug Discovery Foundation (GDAPB-201807-2015632)
BrightFocus Foundation (A2021033S)
U.S. Department of Defense (W81XWH2010849)
Foundation for the National Institutes of Health (K99-AG062723, R01AG044546, P01AG003991, RF1AG053303, R01AG058501, U01AG058922, K01AG046374, R01HL119813, P30 AG066444)
National Institute on Aging (U19AG032438)
Alzheimer's Association (SG-20-690363-DIAN)
Deutsches Zentrum für Neurodegenerative Erkrankungen
Institute for Neurological Research Dr. Raul Carrea
Japan Agency for Medical Research and Development
Korea Health Industry Development Institute
Instituto de Salud Carlos III
Canadian Institutes of Health Research
Canadian Consortium of Neurodegeneration and Aging
Brain Canada Foundation
Fonds de Recherche du Québec - Santé
Article History
Received: 10 December 2021
Accepted: 7 February 2022
First Online: 4 March 2022
Declarations
:
: The Institutional Review Boards of Washington University School of Medicine in St. Louis approved the study, and research was carried out in accordance with the approved protocols. Written informed consent was obtained from all participants or their family members.
: All authors read and approved the final manuscript.
: The authors report no competing interests in relation to this manuscript.